On this episode of HALO Talks, host Pete Moore sits down with Chris Mirabile, founder of NOVOS, for an inspiring conversation about the science of longevity, the importance of preventative health, and the journey from personal health crises to building an impactful company in the supplement space. Chris shares his compelling story of surviving a brain tumor at age 16 which launched his lifelong passion for optimizing long-term health, and reveals how that experience shaped his unique view on wellness and aging. The conversation goes into the challenges of building credibility in a noisy market, and the rigorous scientific process (and team) behind NOVOS' approach.

Expect to hear insights on biological aging versus chronological age, the steps NOVOS takes with clinical trials and advisory board selection, strategies for building a mission-driven company, and how to stay authentic amid the wellness industry's hype.

Whether you're an entrepreneur, a health enthusiast, or just curious about the future of aging, this episode offers a blend of personal conviction, actionable business advice, and leading-edge science.

Regarding a recent Mayo Clinic endorsement Chris says, "Some of the practitioners, including the head of longevity medicine at Mayo Clinic Arizona said, 'I want to recommend this to my patients. I want it readily available at the Mayo Clinic store.' So that, that is something that is really symbolic."

Key themes discussed

• Personal journey inspiring longevity focus
• Evolution of health terminology: Wellness, anti-aging, longevity
• Human psychology, short-term vs. long-term health goals
• Building a respected scientific advisory board
• Competition in the longevity and supplement industry
• Scientific validation and clinical trials for NOVOS
• Measuring and reducing biological age with epigenetic tests

A Few Key Takeaways:

1.Personal Health Crisis Sparked a Lifelong Passion: Chris shared how being diagnosed with a brain tumor at age 16 completely reshaped his outlook on health, shifting his priorities from aesthetics and performance to long-term health, disease avoidance, and optimal well-being.

2. The Language of Longevity Matters: Both Pete and Chris discussed the evolution of words used in the industry. Mirabile isn't a fan of "anti-aging," and prefers "longevity," emphasizing a holistic, forward-looking approach to health focusing on long-term outcomes rather than quick fixes.

3. Bridging Science and Supplements with Credibility: Chris described how NOVOS set itself apart by investing years into R&D, building relationships with renowned scientists (like Dr. George Church), and producing clinical trials for their products, standing in contrast to the more hype-driven supplement companies.

4. The Importance of Short-term and Long-term Benefits: A key insight Chris stressed is that compliance is crucial. NOVOS products are formulated to offer both immediate benefits (so users feel a difference) and actual long-term health impacts, supporting both "healthspan" and "lifespan."

5. Biological Age Testing and Results: NOVOS offers an epigenetic biological age test called Novos Age, which Mirabile says is one of the most scientifically grounded tools available. Initial data suggests that consistent use of NOVOS supplements can help users "slow down" or even reduce their biological aging rate.

Resources:

• Chris Mirabile: https://www.linkedin.com/in/chrismirabile
• NOVOS: https://novoslabs.com
• Integrity Square: https://www.integritysq.com
• Prospect Wizard: https://www.theprospectwizard.com
• Promotion Vault: https://www.promotionvault.com
• HigherDose: https://www.higherdose.com